Account
Contract advertising wins the UTI Mutual Fund business
MUMBAI: Contract Advertising has won the creative mandate for UTI Mutual Fund (UTI MF). The business will be handled by the agency’s Mumbai office, which won the account over a multi-agency pitch.
On winning the business, Contract India COO Rana Barua says, “We are extremely happy to partner with UTI MF. This gives us a fabulous opportunity to work with a legendary brand in a category that has great scope for gaining prominence in the current economic situation. Our partnership will also be focused at bringing back the relevance of sound investment in the life of the new-age consumers.”
UTI MF will celebrate its golden jubilee in February and has a series of activities planned throughout the year to commemorate the occasion.
UTI AMC’s managing director Leo Puri said, “We are happy to appoint Contract Advertising as the lead creative agency of UTI. Contract Advertising has been chosen through a multi-agency evaluation process for its strategic thinking, consumer insight and experience across multiple categories.”
“This year, UTI will be celebrating its golden jubilee. 50 years marks a strong milestone in the history of UTI, an Institution which has been the pioneer in the wealth creation since 1964. As we look to accelerate our growth going forward, Contract Advertising will help us to create the brand salience.” Mr. Puri added
The agency will put together a 360 degree campaign for UTI MF across TV, print, radio, out-of-home and digital that will herald 50 years of the brand that has been in existence for five decades.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
